Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Junji, Yamashita"'
Autor:
Yuichi Kojima, Atsunori Tsuchiya, Masahiro Ogawa, Shunsuke Nojiri, Suguru Takeuchi, Takayuki Watanabe, Kenji Nakajima, Yukio Hara, Junji Yamashita, Junichi Kikuta, Masaaki Takamura, Masaru Ishii, Shuji Terai
Publikováno v:
Regenerative Therapy, Vol 11, Iss , Pp 269-281 (2019)
Background: Mesenchymal stem cells (MSCs) can be easily expanded. They can be acquired from medical waste such as adipose and umbilical cord tissues, are influenced by culturing conditions, and exert anti-inflammatory, antioxidant, anti-fibrotic, and
Externí odkaz:
https://doaj.org/article/5ea85cfe542a432b9eed67c99d7d4550
Publikováno v:
Japanese Geotechnical Journal. 17:433-449
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba929ba293374116b8c68faef7a3bf85
https://doi.org/10.3208/jgs.17.433
https://doi.org/10.3208/jgs.17.433
Autor:
Manabu Hayata, Junji Yamashita, Kentaro Tokunaga, Masashi Ejima, Katsuyuki Sagishima, Shigeki Nakagawa, Daisuke Hashimoto, Hideo Baba, Kosuke Maruyama, Yu Kohrogi, Teruhiko Mizumoto, Masashi Mukoyama, Hidenobu Kamohara
Publikováno v:
Renal Replacement Therapy, Vol 3, Iss 1, Pp 1-6 (2017)
Abstract Background Patients with end-stage renal disease are in an immune-compromised state, with infection being the most common cause of mortality among those undergoing dialysis. Case presentation A 73-year-old woman who had received 6 months of
Externí odkaz:
https://doaj.org/article/5d91c9eead854087b69e347578dcb53f
Autor:
Hironobu Ihn, Masatoshi Jinnin, Yasuharu Nishimura, Satoru Senju, Miwa Haruta, Jun Aoi, Junji Yamashita, Aki Tokuzumi, Yosuke Kubo, Satoshi Nakahara, Satoshi Fukushima, Azusa Miyashita
We observed malignant tumor development from human iPS-ML-IFN cells in SCID mice for up to 12 weeks. During the observation period, the mice were healthy, and no significant difference was observed in the body weight of human iPS-ML-IFN-injected mice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be0bb70fefd82b2d50fdb4476533e60d
https://doi.org/10.1158/2326-6066.22537568
https://doi.org/10.1158/2326-6066.22537568
Autor:
Hironobu Ihn, Masatoshi Jinnin, Yasuharu Nishimura, Satoru Senju, Miwa Haruta, Jun Aoi, Junji Yamashita, Aki Tokuzumi, Yosuke Kubo, Satoshi Nakahara, Satoshi Fukushima, Azusa Miyashita
In recent years, immunotherapy for advanced melanoma has been gaining increased attention. The efficacy of anti-cytotoxic T-lymphocyte antigen 4 antibodies, anti-programmed cell death 1 antibodies, and the BRAFV600E kinase inhibitor has been proven i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5490447426deb5ae6ecfa44cdceac240
https://doi.org/10.1158/2326-6066.c.6548480.v1
https://doi.org/10.1158/2326-6066.c.6548480.v1
Autor:
Masaru Ishii, Junichi Kikuta, Atsunori Tsuchiya, Masaaki Takamura, Kenji Nakajima, Hara Yukio, Masahiro Ogawa, Suguru Takeuchi, Shunsuke Nojiri, Yuichi Kojima, Junji Yamashita, Shuji Terai, Takayuki Watanabe
Publikováno v:
Regenerative Therapy, Vol 11, Iss, Pp 269-281 (2019)
Regenerative Therapy
Regenerative Therapy
Background Mesenchymal stem cells (MSCs) can be easily expanded. They can be acquired from medical waste such as adipose and umbilical cord tissues, are influenced by culturing conditions, and exert anti-inflammatory, antioxidant, anti-fibrotic, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::796000c604663d3d982bebac495f5eed
http://www.sciencedirect.com/science/article/pii/S2352320419300811
http://www.sciencedirect.com/science/article/pii/S2352320419300811
Autor:
Azusa Miyashita, Satoshi Fukushima, Satoshi Nakahara, Junji Yamashita, Aki Tokuzumi, Jun Aoi, Asako Ichihara, Hisashi Kanemaru, Masatoshi Jinnin, Hironobu Ihn
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0144241 (2015)
Recent studies have shown that immunotherapies and molecular targeted therapies are effective for advanced melanoma. Non-antigen-specific immunotherapies such as immunocheckpoint blockades have been shown to be effective in the treatment of advanced
Externí odkaz:
https://doaj.org/article/68f18cff6df44cbfb3777e62ee8ea776
Autor:
Tetsuya Sasaki, Atsushi Onodera, Hiroyuki Hosokawa, Yukiko Watanabe, Shu Horiuchi, Junji Yamashita, Hitoshi Tanaka, Yasumasa Ogawa, Yutaka Suzuki, Toshinori Nakayama
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e66468 (2013)
Functionally polarized CD4+ T helper (Th) cells such as Th1, Th2 and Th17 cells are central to the regulation of acquired immunity. However, the molecular mechanisms governing the maintenance of the polarized functions of Th cells remain unclear. GAT
Externí odkaz:
https://doaj.org/article/8854dc8de0da43f19e7620218ad89683
Autor:
Hideo Baba, Manabu Hayata, Teruhiko Mizumoto, Kosuke Maruyama, Katsuyuki Sagishima, Masashi Ejima, Shigeki Nakagawa, Yu Kohrogi, Hidenobu Kamohara, Junji Yamashita, Masashi Mukoyama, Kentaro Tokunaga, Daisuke Hashimoto
Publikováno v:
Renal Replacement Therapy, Vol 3, Iss 1, Pp 1-6 (2017)
Background Patients with end-stage renal disease are in an immune-compromised state, with infection being the most common cause of mortality among those undergoing dialysis. Case presentation A 73-year-old woman who had received 6 months of peritonea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47d138adecb4030bae3d7450eb8cf456
http://link.springer.com/article/10.1186/s41100-017-0132-9
http://link.springer.com/article/10.1186/s41100-017-0132-9
Publikováno v:
Brain and nerve = Shinkei kenkyu no shinpo. 71(5)
Myasthenia gravis (MG) is an inflammatory disorder caused by autoantibodies against the nicotinic acetylcholine receptor (AChR). New therapeutic options for MG are required because the conventional treatments cannot always achieve long-term remission
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ac413693fd1df2b51499aa25ff62e723
https://pubmed.ncbi.nlm.nih.gov/31089000
https://pubmed.ncbi.nlm.nih.gov/31089000